Rapivab 600mg/60mL IV Solution from Japan
Branded Rapivab peramivir injection 600mg in 60mL ready-to-use IV bags for influenza treatment. HTS 3004.90.92.05 due to peramivir content in measured prophylactic/therapeutic doses for retail sale.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Document complete cold chain from manufacture to entry per FDA guidance
• Provide drug master files for excipients in IV formulation
• Ensure overwrap removal instructions included for ready-to-use bags